Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07496541

Serum Copeptin as Biomarker for Diagnosis and Classification of Polyuric Primary Monosymptomatic Nocturnal Enuresis

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
The Children's Hospital of Zhejiang University School of Medicine · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Accepted

Summary

Primary monosymptomatic nocturnal enuresis (PMNE) is one of the most common urinary system problems in childhood. The exact pathological mechanism has not been fully elucidated yet, but excessive nocturnal urination is considered one of the core pathogenic mechanisms. Studies have found that a considerable number of PMNE patients have abnormal secretion of arginine vasopressin (AVP) at night. Currently, the "gold standard" for diagnosing nocturnal polyuria is through a voiding diary, which is cumbersome and the records may contain errors, and there are many inconveniences in clinical implementation. Therefore, finding objective and simple biomarkers to assist in diagnosis and classification is a current clinical research hotspot. Copeptin is the C-terminal fragment of the precursor protein of AVP and is released into the blood simultaneously at the same molar ratio as AVP, making it an ideal alternative biomarker for AVP. This study aims to systematically and deeply explore the diagnostic value of serum copeptin in PMNE, especially in its different subtypes (NP-PMNE vs. NNP-PMNE), analyze its correlation with clinical severity, and explore more precise detection strategies, in order to provide new and objective biological tools for the clinical management of PMNE.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcopeptin levels in NP-PMNETesting the level of copeptin in patients with NP-PMNE
DIAGNOSTIC_TESTTesting the level of copeptin in patients with NNP-PMNETesting the level of copeptin in patients with NNP-PMNE
DIAGNOSTIC_TESTTesting the level of copeptin in healthy childrenTesting the level of copeptin in healthy children

Timeline

Start date
2026-03-17
Primary completion
2028-12-31
Completion
2029-01-31
First posted
2026-03-27
Last updated
2026-03-27

Source: ClinicalTrials.gov record NCT07496541. Inclusion in this directory is not an endorsement.